Immune-cell numbers predict response to combination immunotherapy in melanoma
Thursday, July 20, 2017 - 10:32
in Health & Medicine
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study.